Menu Search
Equities

Teladoc Health Inc

0LDR:LSE

Teladoc Health Inc

Actions
  • Price (USD)9.96
  • Today's Change0.004 / 0.04%
  • Shares traded6.33k
  • 1 Year change-37.74%
  • Beta--
Data delayed at least 20 minutes, as of Nov 13 2024 14:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.

  • Revenue in USD (TTM)2.59bn
  • Net income in USD-981.73m
  • Incorporated2008
  • Employees5.60k
  • Location
    Teladoc Health Inc2 Manhattanville Rd Ste 203PURCHASE 10577-2118United StatesUSA
  • Phone+1 (203) 635-2002
  • Fax+1 (302) 636-5454
  • Websitehttps://www.teladochealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.